Veradigm | MDRX - Ativos

Preço das Ações
4.58
Mudança Diária
-0.07 -1.40%
Mensal
1.78%
Anual
7.76%
Q1 Previsão
4.44




Ativos Alterar Data
Alcidion AUD 118.08M 2.46M 2025-12
Ambu A/S DKK 7.58B 94M 2025-12
Amplifon EUR 3.53B 336.5M 2025-09
Cardinal Health USD 58.08B 2.86B 2025-12
Centene USD 76.75B 5.34B 2025-12
Charles River Laboratories USD 7.14B 378.39M 2025-12
Cigna USD 157.92B 0 2025-12
Coloplast 48.8B 429M 2025-12
Computer Programs Systems USD 399.41M 9.26M 2025-09
Convatec Group USD 3.52B 109.3M 2024-12
CVS Health USD 253.54B 1.79B 2025-12
Diasorin EUR 2.87B 257.21M 2025-06
Elevance Health USD 121.49B 1.26B 2025-12
General Electric Aerospace USD 130.17B 1.93B 2025-12
Gulf Medical Proj AED 1.55B 85.18M 2025-12
Humana USD 48.91B 810M 2025-12
IQVIA Holdings USD 29.94B 1.22B 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Maximus USD 4.21B 138.66M 2025-12
McKesson USD 84.19B 30M 2025-12
Med Life RON 3.26B 116.56M 2025-12
Molina Healthcare USD 15.56B 134M 2025-12
Omnicell USD 1.97B 26.12M 2025-12
Oriola-kd EUR 946.1M 22.7M 2025-12
Owens Minor USD 2.45B 1.58B 2025-12
Quest Diagnostics USD 16.23B 28M 2025-12
Rede D'or Sao Luiz BRL 106.55B 3.48B 2025-12
Siemens Healthineers EUR 44.27B 104M 2025-12
Sonova Holding CHF 5.92B 468.2M 2025-06
Supermax Corporation Bhd MYR 4.17B 125.99M 2025-12
UnitedHealth USD 309.58B 5.69B 2025-12
Veeva Systems USD 8.98B 882.19M 2025-12
Veradigm USD 1.5B 185.94M 2022-12
Xerox USD 10.07B 1.19B 2025-09